According to IQVIA sales data for the 12-month period ending November 2021, the MetroGel-Vaginal Gel achieved annual sales of approximately around USD 60.4 million. Glenmark’s current portfolio consists of 173 products authorised for distribution in the US marketplace and 46 ANDA’s pending approval with the USFDA.
